MIRA Stock Analysis: Buy, Sell, or Hold?
MIRA - MIRA Pharmaceuticals, Inc. Common Stock
$0.80
0.04 (4.77%)
â˛
5d:
+1.27%
30d:
-9.28%
90d:
-19.35%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When MIRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: MIRA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: MIRA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: MIRA is currently trading at $0.80, which is considered fair relative to its 30-day fair value range of $0.71 to $0.89.
Technical Outlook: Technically, MIRA is in a strong downtrend. Immediate support is located at $0.71, while resistance sits at $0.82. The stock is showing strong short-term momentum, up 4.8% recently.
Market Sentiment: MIRA scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $17.75 (+2224.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MIRA is in a strong downtrend. Immediate support is located at $0.71, while resistance sits at $0.82. The stock is showing strong short-term momentum, up 4.8% recently.
Market Sentiment: MIRA scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $17.75 (+2224.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.71 -
$0.89
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
92.1%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (65/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.8%)
- BULLISH: Trading 2224.5% below Wall St target ($17.75)
- WARNING: Composite score 46/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.71 -
$0.89
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.71
Resistance Level
$0.83
Current Trend
Strong Downtrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.86
Wall Street Target
$17.75
(+2224.5%)
Share & Embed Analysis
Last updated: August 24, 2026 12:23 PM ET
Data refreshes hourly during market hours. Next update: 1:23 PM
Data refreshes hourly during market hours. Next update: 1:23 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MIRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
31 analysts |
$1315 | 37 SELL |
|
GILD
Gilead Sciences Inc |
BUY
30 analysts |
$157 | 34 SELL |
|
ABBV
AbbVie Inc |
BUY
28 analysts |
$277 | 41 HOLD |
|
BIIB
Biogen Inc |
HOLD
37 analysts |
$236 | 42 HOLD |
|
AMGN
Amgen Inc |
HOLD
32 analysts |
$388 | 38 SELL |
